Hardman Johnston Global Advisors LLC trimmed its position in Leidos Holdings, Inc. (NYSE:LDOS – Free Report) by 13.4% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 90,100 shares of the aerospace company’s stock after selling 14,000 shares during the quarter. Hardman Johnston Global Advisors LLC’s holdings in Leidos were worth $14,686,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other hedge funds and other institutional investors have also bought and sold shares of LDOS. Northwest Investment Counselors LLC bought a new position in Leidos in the 3rd quarter worth approximately $30,000. 1832 Asset Management L.P. acquired a new stake in shares of Leidos in the second quarter worth $34,000. Blue Trust Inc. increased its position in Leidos by 251.3% during the second quarter. Blue Trust Inc. now owns 281 shares of the aerospace company’s stock worth $41,000 after acquiring an additional 201 shares during the period. Massmutual Trust Co. FSB ADV raised its stake in Leidos by 122.5% during the 2nd quarter. Massmutual Trust Co. FSB ADV now owns 307 shares of the aerospace company’s stock valued at $45,000 after purchasing an additional 169 shares during the last quarter. Finally, Kathleen S. Wright Associates Inc. bought a new stake in Leidos in the 3rd quarter valued at $46,000. 76.12% of the stock is currently owned by institutional investors and hedge funds.
Analyst Ratings Changes
Several research analysts have recently issued reports on the stock. Citigroup boosted their price objective on shares of Leidos from $194.00 to $220.00 and gave the stock a “buy” rating in a report on Wednesday, October 30th. The Goldman Sachs Group boosted their price target on Leidos from $205.00 to $228.00 and gave the company a “buy” rating in a research note on Wednesday, October 30th. Truist Financial raised their price objective on Leidos from $175.00 to $205.00 and gave the stock a “buy” rating in a research report on Wednesday, October 30th. JPMorgan Chase & Co. lifted their price objective on Leidos from $175.00 to $185.00 and gave the stock an “overweight” rating in a report on Wednesday, October 2nd. Finally, Barclays raised their target price on Leidos from $165.00 to $210.00 and gave the stock an “overweight” rating in a research report on Monday. Two research analysts have rated the stock with a hold rating, eleven have given a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $191.23.
Insider Activity at Leidos
In other Leidos news, Director Robert C. Kovarik, Jr. sold 1,047 shares of the business’s stock in a transaction on Thursday, October 31st. The stock was sold at an average price of $184.94, for a total value of $193,632.18. Following the transaction, the director now owns 6,408 shares of the company’s stock, valued at approximately $1,185,095.52. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. In other Leidos news, Director Robert C. Kovarik, Jr. sold 1,047 shares of the firm’s stock in a transaction dated Thursday, October 31st. The shares were sold at an average price of $184.94, for a total value of $193,632.18. Following the completion of the sale, the director now owns 6,408 shares in the company, valued at approximately $1,185,095.52. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, Director Gary Stephen May sold 1,000 shares of the stock in a transaction that occurred on Tuesday, August 13th. The shares were sold at an average price of $144.02, for a total transaction of $144,020.00. Following the sale, the director now directly owns 11,264 shares in the company, valued at $1,622,241.28. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 0.96% of the company’s stock.
Leidos Stock Up 2.0 %
Shares of NYSE LDOS opened at $190.07 on Wednesday. The business has a fifty day moving average of $164.36 and a two-hundred day moving average of $152.46. The company has a debt-to-equity ratio of 0.87, a quick ratio of 1.15 and a current ratio of 1.23. Leidos Holdings, Inc. has a 52-week low of $102.21 and a 52-week high of $190.25. The stock has a market cap of $25.36 billion, a PE ratio of 21.65, a PEG ratio of 1.45 and a beta of 0.68.
Leidos (NYSE:LDOS – Get Free Report) last announced its quarterly earnings results on Tuesday, October 29th. The aerospace company reported $2.93 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.96 by $0.97. The firm had revenue of $4.19 billion during the quarter, compared to the consensus estimate of $4.06 billion. Leidos had a net margin of 7.37% and a return on equity of 30.31%. The firm’s quarterly revenue was up 6.9% on a year-over-year basis. During the same period last year, the firm posted $2.03 EPS. As a group, equities research analysts expect that Leidos Holdings, Inc. will post 10.07 earnings per share for the current fiscal year.
Leidos Increases Dividend
The firm also recently declared a quarterly dividend, which will be paid on Tuesday, December 31st. Investors of record on Monday, December 16th will be given a dividend of $0.40 per share. The ex-dividend date is Friday, December 13th. This is a positive change from Leidos’s previous quarterly dividend of $0.38. This represents a $1.60 dividend on an annualized basis and a yield of 0.84%. Leidos’s dividend payout ratio is 17.31%.
Leidos Company Profile
Leidos Holdings, Inc, together with its subsidiaries, provides services and solutions in the defense, intelligence, civil, and health markets in the United States and internationally. The company operates through Defense Solutions, Civil, and Health segments. The Defense Solutions segment offers national security solutions and systems for air, land, sea, space, and cyberspace for the U.S.
Read More
- Five stocks we like better than Leidos
- Do Real Estate Investment Trusts Deserve a Place in Your Portfolio?
- AMD: The AI Disruptor – Is It Time to Follow Big Tech’s Lead?
- The Most Important Warren Buffett Stock for Investors: His Own
- Analysts Signal Big Upside: Top 3 Stocks to Watch Right Now
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- Bears Misjudged These 3 ETFs: Where Investors Can Find Upside
Want to see what other hedge funds are holding LDOS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Leidos Holdings, Inc. (NYSE:LDOS – Free Report).
Receive News & Ratings for Leidos Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Leidos and related companies with MarketBeat.com's FREE daily email newsletter.